Filing Flows › OmniAb (OABI) › R&D spending
OmniAb (OABI) R&D spending by quarter
OmniAb's R&D spending was $9.6M in Q3 2026 (third quarter 2026), -0.3% from Q2 2026. Over the last 7 quarters it ranged from $9.6M (Q3 2026) to $13.9M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.6M | -0.3% | -8% |
| Q2 2026 | $9.6M | -0.6% | -12% |
| Q1 2026 | $9.6M | -31% | -24% |
| Q4 2025 | $13.9M | +34% | — |
| Q3 2025 | $10.4M | -4% | — |
| Q2 2025 | $10.9M | -14% | — |
| Q1 2025 | $12.6M | — | — |
Q3 2026 at a glance
OmniAb, Q3 2026: revenue $4.0M (+78% year over year), operating margin -409.9%, net loss $15.7M, operating cash flow $10.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is OmniAb's R&D spending?
OmniAb's R&D spending was $9.6M in Q3 2026 (third quarter 2026), -0.3% from Q2 2026.
How has OmniAb's R&D spending changed?
Over the last 7 quarters it ranged from $9.6M (Q3 2026) to $13.9M (Q4 2025).